| Cell line name |
FM60 |
|---|
| Accession |
CVCL_C597 |
|---|
| Resource Identification Initiative |
To cite this cell line use: FM60 (RRID:CVCL_C597) |
|---|
| Sequence variations |
|
|---|
| Disease |
Cutaneous melanoma (NCIt: C3510) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Sex unspecified |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=7656272; DOI=10.1007/BF01527402; PMCID=PMC11037630
Kirkin A.F., Petersen T.R., Olsen A.C., Li L., thor Straten P., Zeuthen J.
Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines.
Cancer Immunol. Immunother. 41:71-81(1995) PubMed=8665567; DOI=10.1007/s002620050272; PMCID=PMC11037612
Kirkin A.F., thor Straten P., Zeuthen J.
Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens.
Cancer Immunol. Immunother. 42:203-212(1996) PubMed=8968104
Bartkova J., Lukas J., Guldberg P., Alsner J., Kirkin A.F., Zeuthen J., Bartek J.
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Cancer Res. 56:5475-5483(1996) PubMed=9288767
Guldberg P., thor Straten P., Birck A., Ahrenkiel V., Kirkin A.F., Zeuthen J.
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Cancer Res. 57:3660-3663(1997) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54835055
|
|---|
| Polymorphism and mutation databases |
Cosmic; 808551
Cosmic; 851442
Cosmic; 1006230
|
|---|
| Entry history |
|---|
| Entry creation | 22-Oct-2012 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 10 |
|---|
